PureTech Health Statistics
Total Valuation
PureTech Health has a market cap or net worth of 440.84 million. The enterprise value is 204.16 million.
| Market Cap | 440.84M |
| Enterprise Value | 204.16M |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 240.19M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -7.34% |
| Shares Change (QoQ) | -10.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 164.78M |
Valuation Ratios
The trailing PE ratio is 8.24.
| PE Ratio | 8.24 |
| Forward PE | n/a |
| PS Ratio | 91.31 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.82 |
| EV / Sales | 39.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.52 |
Financial Position
The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.41.
| Current Ratio | 9.33 |
| Quick Ratio | 9.19 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.23 |
| Interest Coverage | -13.54 |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is -14.55%.
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | -13.10% |
| Return on Invested Capital (ROIC) | -14.55% |
| Return on Capital Employed (ROCE) | -24.21% |
| Revenue Per Employee | 86,214 |
| Profits Per Employee | 955,536 |
| Employee Count | 56 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.11% in the last 52 weeks. The beta is 0.87, so PureTech Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -42.11% |
| 50-Day Moving Average | 1.66 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 56.30 |
| Average Volume (20 Days) | 29 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PureTech Health had revenue of 4.83 million and earned 53.51 million in profits. Earnings per share was 0.21.
| Revenue | 4.83M |
| Gross Profit | -64.40M |
| Operating Income | -135.87M |
| Pretax Income | 23.77M |
| Net Income | 53.51M |
| EBITDA | -134.06M |
| EBIT | -135.87M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 378.69 million in cash and 165.58 million in debt, giving a net cash position of 213.11 million.
| Cash & Cash Equivalents | 378.69M |
| Total Debt | 165.58M |
| Net Cash | 213.11M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 407.93M |
| Book Value Per Share | 1.73 |
| Working Capital | 344.87M |
Cash Flow
In the last 12 months, operating cash flow was -134.37 million and capital expenditures -11,000, giving a free cash flow of -134.38 million.
| Operating Cash Flow | -134.37M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -134.38M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,814.19% |
| Pretax Margin | 492.42% |
| Profit Margin | 1,108.33% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PureTech Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.34% |
| Shareholder Yield | n/a |
| Earnings Yield | 12.14% |
| FCF Yield | -30.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PureTech Health has an Altman Z-Score of 1.88. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | n/a |